Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain

By Rauck Richard L.   Tark Marvin   Reyes Eva   Hayes Teresa G.   Bartkowiak Anthony J.   Hassman David   Nalamachu Srinivas   Derrick Rob   Howell Julian  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2877-2885

Informa Healthcare

Access to resources Recommend Favorite

Long-term effectiveness and tolerability of sublingual fentanyl orally disintegrating tablet for the treatment of breakthrough cancer pain

By Nalamachu Srinivas   Hassman David   Wallace Mark S.   Dumble Sam   Derrick Rob   Howell Julian  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 519-530

Informa Healthcare

Access to resources Recommend Favorite

Patient Satisfaction with Fentanyl Sublingual Spray in Opioid‐Tolerant Patients with Breakthrough Cancer Pain

By  

PAIN PRACTICE, Vol. 15, Iss. 6, 2015-07 ,pp. : 554-563

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fentanyl buccal tablet in breakthrough cancer pain

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 19, Iss. 4, 2015-04 ,pp. : 528-537

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer

By Vissers Debby   Stam Wiro   Nolte Thomas   Lenre Malin   Jansen Jeroen  

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1037-1045

Informa Healthcare

Access to resources Recommend Favorite